Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Will GNC Holdings (GNC) Disappoint This Earnings Season?

Published 10/19/2017, 10:02 PM
Updated 07/09/2023, 06:31 AM

GNC Holdings, Inc. (NYSE:GNC) , a specialty retailer of health and nutrition related products, is scheduled to report third-quarter 2017 results on Oct 26, before the opening bell.

Last quarter, the company posted a positive earnings surprise of 2.5%. However, GNC Holdings’ trailing four-quarter earnings average miss stands at 19.9%.

Let’s see how things are shaping up prior to this announcement.

Factors at Play

GNC Holdings' last reported second-quarter 2017 revenues dropped 4.8% year over year. Apart from lower sales at the U.S. & Canada international and manufacturing/wholesale segments, the decline in revenues can be attributed to an overall drop in sales of protein, vitamins, weight management and food and drink categories. In absence of any catalyst to drive growth, we expect a similar trend in the third quarter of 2017 as well.

Moreover, GNC Holdings has a number of competitors in the market that include large international pharmacy chains, supermarket firms and big U.S.-based companies with global operations. Thus, we expect the company to slash product prices in the face of stiff competition, which in turn, might hurt margins.

GNC Holdings, Inc. Price and EPS Surprise

GNC Holdings, Inc. Price and EPS Surprise | GNC Holdings, Inc. Quote

Also, currency headwinds continue to be a growing concern for GNC Holdings. Management also expects the failure to comply with FTC regulations and changing consumer preferences to hamper business.

However, on the bright side, the performance of One New GNC is improving gradually. Also, in the last reported quarter, PRO Access members doubled their visits, purchased double the products and spent significantly more in the second quarter. Banking on these factors, we expect the company to continue to gain in the yet-to-be-reported quarter as well. Meanwhile, new consumer enrolment under the myGNC Rewards Program and launch of GNC storefront on Amazon (NASDAQ:AMZN) buoy optimism.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Earnings Whispers

Our proven model does not conclusively show an earnings beat for GNC Holdings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here, as you will see below.

Zacks ESP: The Earnings ESP for GNC Holdings is -14.50%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Zacks Rank: GNC Holdings carries a Zacks Rank #3, which increases the predictive power of ESP. However, we also need to have a positive ESP to be confident of a positive earnings surprise.

Stocks to Consider

Here are a few medical stocks worth considering as they have the right combination of elements to post an earnings beat this quarter.

The Cooper Companies, Inc. (NYSE:COO) has an Earnings ESP of +0.43% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Henry Schein, Inc. (NASDAQ:HSIC) has an Earnings ESP of +0.62% and a Zacks Rank #3.

Thermo Fisher Scientific Inc. (NYSE:TMO) has an Earnings ESP of +0.33% and a Zacks Rank #2.

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>



3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Thermo Fisher Scientific Inc (TMO): Free Stock Analysis Report

Henry Schein, Inc. (HSIC): Free Stock Analysis Report

Cooper Companies, Inc. (The) (COO): Free Stock Analysis Report

GNC Holdings, Inc. (GNC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.